Market Place
Sourcing Support
Biohaven Completes Enrollment Of Verdiperstat Arm Of Pivotal Healey ALS
15 Nov 2021 //
PRNEWSWIRE
Biohaven`s CNS drug from AstraZeneca fails phase 3 trial
28 Sep 2021 //
REUTERS
Biohaven Announces Enrollment Of First Patients In Pivotal HEALEY ALS Platform
03 Aug 2020 //
PRESS RELEASE
Biohaven Completes Enrollment Ahead Ph3 Clinical Trial of Verdiperstat
21 Jul 2020 //
PRNEWSWIRE
Biohaven`s Verdiperstat Receives Fast Track Designation
18 Mar 2020 //
PRNEWSWIRE
Biohaven Enrolls First Patient In Pha3 Clinical Trial Of Verdiperstat
31 Jul 2019 //
PR NEWSWIRE
Biohaven`s Verdiperstat Receives Orphan Drug Designation From FDA For MSA
19 Feb 2019 //
PR NEWSWIRE
Biohaven picks up AstraZeneca CNS drug, plans phase 3
07 Sep 2018 //
FIERCE BIOTECH
After rare disease failure, Biohaven pushes the gas on oral migraine drug
27 Nov 2017 //
FIERCE BIOTECH
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.